Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 79

Results For "General"

844 News Found

Apollo Hospitals Bangalore first to hit a century of robotic cardiac surgeries
Healthcare | September 07, 2021

Apollo Hospitals Bangalore first to hit a century of robotic cardiac surgeries

In comparison to traditional open-heart surgery, which involves opening up the chest by splitting the breastbone, da Vinci Xi's innovative technology allows for complex cardiovascular surgeries to be performed through smaller incisions and precise motion control


Healthium Medtech files DRHP for IPO
Startup | September 07, 2021

Healthium Medtech files DRHP for IPO

As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value


Anti-dumping duty proposed on Vitamin C from China for five years
News | September 07, 2021

Anti-dumping duty proposed on Vitamin C from China for five years

The DGTR has recommended US $ 3.2 per kg and US $ 3.55 per kg duty on imports


DGCI approves Hetero’s Tocilizumab
Drug Approval | September 06, 2021

DGCI approves Hetero’s Tocilizumab

Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month


Reliance Life Science gets go-ahead for Phase I clinical trial for Covid-19 vaccine
Drug Approval | September 04, 2021

Reliance Life Science gets go-ahead for Phase I clinical trial for Covid-19 vaccine

The trial will be conducted across eight sites in Maharashtra


DGCI green lights Biological E for Phase 2/3 trials of its Covid-19 vaccine candidate for children
Biotech | September 03, 2021

DGCI green lights Biological E for Phase 2/3 trials of its Covid-19 vaccine candidate for children

The trial will be conducted across 10 sites in India


CII awards Excellence in Energy efficiency to Sai Life Sciences API unit
Sustainability | September 03, 2021

CII awards Excellence in Energy efficiency to Sai Life Sciences API unit

The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL


Reddy-Lenalidomide launched in Canada
Drug Approval | September 02, 2021

Reddy-Lenalidomide launched in Canada

Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian market


Granules India receive DRDO licence to manufacture and market 2-DG
News | September 02, 2021

Granules India receive DRDO licence to manufacture and market 2-DG

The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19


WHO releases compendium of innovative health technologies
Policy | September 01, 2021

WHO releases compendium of innovative health technologies

The Covid-19 pandemic has exposed the divide that exists between rich and developing nations and to address these challenges the World Health Organisation (WHO), has compiled a list of innovative health technologies that aim to bridge the gap